Zobrazeno 1 - 10
of 26
pro vyhledávání: '"M.-J. Haardt"'
Publikováno v:
Annales d'Endocrinologie. 66:47-49
Autor:
Bruno Guerci, V. Lassmann-Vague, Nathalie Jeandidier, Helene Hanaire-Broutin, Christiane Broussolle, Eric Renard, M. J. Haardt
Publikováno v:
Diabetes Care. 18:388-392
OBJECTIVE To report the overall French experience, obtained through the collaboration of seven centers (EVADIAC [Evaluation dans le Diabète du Traitement par Implants Actifs] register), on the safety, feasibility, and efficacy of intraperitoneal ins
Autor:
Brigitte Mace, Marie-Lou Ramaniche, Jean-Louis Selam, F. Bruzzo, Gérard Slama, M. J. Haardt, Catherine Dorange, Jean-Pierre Bethoux
Publikováno v:
Diabetes Care. 17:847-851
OBJECTIVE To investigate if intraperitoneal (IP) insulin infusion via programmable implantable pumps is a potential alternative to subcutaneous (SC) insulin via multiple injections. RESEARCH DESIGN AND METHODS We compared the cost-benefits of the two
Publikováno v:
Annales d'endocrinologie. 66(1)
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 14(5)
Publikováno v:
The International journal of artificial organs. 19(12)
The aim of this study was to develop a diagnostic procedure for pumping unit malfunction by radionuclide imaging (RI) and to validate the method by comparing the results with those obtained using more conventional methods. Fifteen radionuclide invest
Publikováno v:
Diabetemetabolisme. 21(5)
Autor:
H, Hanaire-Broutin, C, Broussolle, N, Jeandidier, E, Renard, B, Guerci, M J, Haardt, V, Lassmann-Vague
Publikováno v:
Diabetes care. 18(3)
To report the overall French experience, obtained through the collaboration of seven centers (EVADIAC [Evaluation dans le Diabète du Traitement par Implants Actifs] register), on the safety, feasibility, and efficacy of intraperitoneal insulin thera
Publikováno v:
Diabetemetabolisme. 19
Since feasibility is now proven, cost-efficacy of external sub-cutaneous (EXT) and implantable programmable (IMP) insulin pumps needs to be compared to those of intensified conventional insulin therapy (CONV). Only metabolic efficacy and short-term d
Publikováno v:
Diabetemetabolisme. 17(6)